💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @WALLSTREETODDS_ | 9 |
| @JRMKE3 | 8 |
| @Tickeron | 7 |
| @brendan_49 | 7 |
| @Biotech2k1 | 5 |
Recent Tweets for FATE
 |
@JRMKE3 $FATE We should get an updated investors presentation on the company website in the next three weeks. April 19th 2021, 8:04pm |
 |
@Tickeron $FATE in -4.2% Downtrend, sliding for three consecutive days on April 16, 2021. View odds for this and other indica… https://t.co/iYRXHE9cZA April 19th 2021, 8:04am |
 |
@WALLSTREETODDS_ $FATE Out of the 614 other times FATE was down 3.8% during a trading day, 56% of the time it traded higher by the… https://t.co/kLaAlOg9Gn April 19th 2021, 6:04am |
 |
@Gambiste1 RT @xlp007: $AFMD $FATE They are not enemies! They are allies! We need them hand by hand to save more patients! Following are my personal t… April 19th 2021, 2:04am |
 |
@xlp007 $AFMD $FATE They are not enemies! They are allies! We need them hand by hand to save more patients! Following are m… https://t.co/kfmPQn4e0f April 19th 2021, 1:04am |
|
@WALLSTREETODDS_ $FATE Out of the 614 other times FATE was down 3.8% during a trading day, 56% of the time it traded higher by the… https://t.co/JYh3prS4tu April 18th 2021, 11:04pm |
|
@Gambiste1 RT @csr1223: @BrianUherek Check your $AFMD numbers. Unless you think their patients weigh 1 Kg I think you need to make an adjustment. $FATE April 18th 2021, 10:04pm |
 |
@csr1223 @BrianUherek Check your $AFMD numbers. Unless you think their patients weigh 1 Kg I think you need to make an adjustment. $FATE April 18th 2021, 10:04pm |
 |
@MarcJacksonLA $FATE Fate Therapeutics Receives Consensus Rating of "Buy" from Brokerages | $109.56 Average PT… https://t.co/9wTDJMHQCV April 18th 2021, 2:04pm |
 |
@8thKingofRome @sububoston @PersimmonTI Basically $FATE need to take mabs from third parties while Affimed has its own platform. April 18th 2021, 12:04pm |
|
@Tickeron $FATE in -4.2% Downtrend, sliding for three consecutive days on April 16, 2021. View odds for this and other indica… https://t.co/Z39AEv0RkZ April 18th 2021, 10:04am |
 |
@Rwarner42 RT @PersimmonTI: $AFMD — $FATE Bullish on the fate of both companies, but there’s a reason that Dr. Rezvani calls AFM13+cbNK remarkable.… April 18th 2021, 2:04am |
|
@WALLSTREETODDS_ $FATE Out of the 614 other times FATE was down 3.8% during a trading day, 56% of the time it traded higher by the… https://t.co/FILwE71U6t April 18th 2021, 12:04am |
 |
@sububoston @PersimmonTI so $AFMD cell count /kg and $FATE is absolute. April 17th 2021, 11:04pm |
 |
@PersimmonTI $AFMD — $FATE Bullish on the fate of both companies, but there’s a reason that Dr. Rezvani calls AFM13+cbNK remar… https://t.co/wzqk7SILSB April 17th 2021, 11:04pm |
|
@8thKingofRome @Biotech2k1 No one asked you because no one cares? I Can feel your concerns for $FATE after $AFMD data. But relax t… https://t.co/LHFpytWuso April 17th 2021, 9:04pm |
 |
@Biotech2k1 From what I can tell, $FATE did not present at AACR. That is probably a good thing. I wouldn't want to seem like I… https://t.co/Oaa7mMsySa April 17th 2021, 5:04pm |
|
@WALLSTREETODDS_ $FATE Out of the 614 other times FATE was down 3.8% during a trading day, 56% of the time it traded higher by the… https://t.co/bHUgpSgDB4 April 17th 2021, 2:04am |
|
@WALLSTREETODDS_ $FATE Out of the 397 other times FATE was down 5.1% during a trading day, 60% of the time it traded higher by the… https://t.co/EKisbFYmxB April 16th 2021, 6:04pm |
|
@JRMKE3 $FATE ASGCT abstracts are released on 4/27. Let’s see if AML data is actually happening. April 16th 2021, 4:04pm |
 |
@celltelligence On the fifth day of #AACR21 Week I, two key preclinical CAR-NK updates were reported from $FATE, while the latest N… https://t.co/B9Y2Oj1jIh April 15th 2021, 9:04pm |
 |
@Fateloll $FATE to the moon ? April 15th 2021, 8:04pm |
 |
@LeeSinTrade1 $FATE Trading is easy with Buy and Short signals displayed on the chart: https://t.co/QO01PX5cnq April 15th 2021, 5:04pm |
|
@Biotech2k1 @A_May_MD As someone who as followed $FATE since very early, I do believe they are editing the gnome in the stem ce… https://t.co/ZYfqGK84mX April 15th 2021, 5:04pm |
 |
@brendan_49 @A_May_MD What's the next $FATE catalyst that could make even valuation-sensitive people perk up? I imagine there's… https://t.co/qvq60IBkWX April 15th 2021, 5:04pm |
 |
@JanEhses @A_May_MD @brendan_49 This is literally the $FATE billion dollar question (or multi-billion). How well will iPSC-de… https://t.co/2I8GAneStv April 15th 2021, 5:04pm |
 |
@RVH_Investing $AFMD should be down 25%+. $FATE is the stock to own moving forward in this space April 15th 2021, 2:04pm |
|
@Biotech2k1 I made the hard decision to delete all my spreadsheets and DD from $FATE and $BEAM. I like the companies a lot, but… https://t.co/dzIidSv1PG April 15th 2021, 11:04am |
 |
@mattdelao RT @mattdelao: $FATE Check out this chart I made with @TrendSpider https://t.co/wZxHj6cteJ Alerted last night. Candle vs raindrop. Beauti… April 15th 2021, 4:04am |
 |
@YuZhu4 RT @Prof_Oak_: From BAML group call, more granularity on $FATE catalyst timing than what's been publicly discussed - 516/538 AML data at AS… April 15th 2021, 3:04am |
 |
@NathanPaine7 @jimcramer do you think more speculative biotechs like $pacb and $fate are at a good entry point after taking a bea… https://t.co/kmArlHpWCG April 15th 2021, 2:04am |
|
@derekavinay RT @Amylucio2009: $afmd officially becomes an nk cell therapy company by licensing the product from MDACC $fate https://t.co/Y8lpbiOwEf April 15th 2021, 2:04am |
|
@mattdelao $FATE Check out this chart I made with @TrendSpider https://t.co/wZxHj6cteJ Alerted last night. Candle vs raindro… https://t.co/RxzEiACJlZ April 15th 2021, 12:04am |
 |
@42Stocks https://t.co/GxBRd4lkKB 2021-APR-14 5:55pm $FATE #FateThx Fate up 7.38% = $499.4 million gain. (Apr 14) Zuma Leav… https://t.co/LHuhzCxilm April 14th 2021, 9:04pm |
 |
@Janfr31 RT @Amylucio2009: $afmd officially becomes an nk cell therapy company by licensing the product from MDACC $fate April 14th 2021, 9:04pm |
 |
@Amylucio2009 $afmd officially becomes an nk cell therapy company by licensing the product from MDACC $fate https://t.co/Y8lpbiOwEf April 14th 2021, 9:04pm |
|
@WALLSTREETODDS_ $FATE Out of the 115 other times FATE was up 10.3% during a trading day, 60% of the time it traded lower by the sa… https://t.co/GTiUxC0vG0 April 14th 2021, 6:04pm |
 |
@weeklystockchar $FATE 130m. That looks like a break w/ volume to me. Trying to buy some right now (small size). #130m_bios https://t.co/Mb8tgBOexq April 14th 2021, 6:04pm |
|
@JRMKE3 $FATE Looks like the ovarian study was updated yesterday (FT516) and they have begun. Five total arms! April 14th 2021, 5:04pm |
|
@Tickeron $FATE in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/mSl1dWQ8Hl April 14th 2021, 5:04pm |
 |
@QuantchaIdeas Big Gainer Alert: Trading today’s 8.8% move in FATE THERAPEUTICS INC. COMMON $FATE https://t.co/OS8kGtRpo4 April 14th 2021, 4:04pm |
 |
@A_May_MD @dhovekamp42 @brendan_49 IDK about that. Unlike $AFMD $FATE is *already* going after multiple targets, and target c… https://t.co/4qKRjvU2ny April 14th 2021, 3:04pm |
 |
@dhovekamp42 @brendan_49 @A_May_MD This $FATE narrative completely ignores the real potential of $AFMD ICE being dosed seperatel… https://t.co/mQ0KeYwukV April 14th 2021, 3:04pm |
|
@dhovekamp42 @brendan_49 @A_May_MD The window for $FATE will be quite small unless they continue to partner with $AFMD in which… https://t.co/iOhSRkJ4dX April 14th 2021, 2:04pm |
|
@brendan_49 @Orangeman1992 and partly the tendency to think in terms of ultimate platform potential as if $FATE's gonna put 20… https://t.co/1TtdZTTe3k April 14th 2021, 2:04pm |
|
@brendan_49 @A_May_MD I think $RTVA could compete successfully w/ $FATE for awhile if they're smart. If indeed RTVA's cost/dose… https://t.co/i6n7Uojudj April 14th 2021, 2:04pm |
|
@brendan_49 $AFMD just provided $FATE a rationale for a CD30 CAR w/ unnatural persistence. If FT516 + rituxin looks good then A… https://t.co/YXuTRBBbUu April 14th 2021, 2:04pm |
|
@brendan_49 $FATE and $AFMD are theoretical but not practical competitors. Yes it'll be interesting to someday compare iPSC CAR… https://t.co/m4Wz8oz5Hy April 14th 2021, 2:04pm |
|
@brendan_49 @A_May_MD 1) The most promising NK cell therapies are CAR-NK's $FATE , or synthetic CAR-NKs $AFMD, or NKs + proven… https://t.co/Chc52RNPVt April 14th 2021, 2:04pm |
 |
@Prof_Oak_ From BAML group call, more granularity on $FATE catalyst timing than what's been publicly discussed - 516/538 AML d… https://t.co/HvCaGDhz3f April 14th 2021, 12:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
